| Quarterly Financials | Jun 2019 | Sept 2019 | Dec 2019 | Mar 2020 | Jun 2020 | Sept 2020 | Dec 2020 | Mar 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 |
Revenue  | 270 | 285 | 278 | 275 | 276 | 691 | 835 | 831 | 1,026 | 1,050 | 1,023 | 964 | 1,098 | 1,163 | 1,186 | 1,255 | 1,326 | 1,409 | 1,381 | 1,468 | 1,578 | 1,748 | 1,902 | 1,957 | 2,064 | 2,168 |
| Expenses | 239 | 253 | 245 | 228 | 514 | 564 | 636 | 634 | 756 | 787 | 729 | 729 | 802 | 818 | 828 | 874 | 948 | 976 | 949 | 1,041 | 1,156 | 1,257 | 1,443 | 1,398 | 1,505 | 1,560 |
| EBITDA | 31 | 31 | 32 | 47 | -239 | 127 | 200 | 197 | 270 | 262 | 293 | 235 | 296 | 345 | 359 | 381 | 379 | 433 | 432 | 427 | 422 | 491 | 459 | 559 | 559 | 608 |
| Operating Profit % | 9 % | 10 % | 8 % | 8 % | -101 % | 13 % | 20 % | 21 % | 24 % | 23 % | 25 % | 22 % | 25 % | 28 % | 28 % | 28 % | 26 % | 28 % | 29 % | 27 % | 25 % | 26 % | 23 % | 27 % | 26 % | 27 % |
| Depreciation | 12 | 11 | 11 | 12 | 26 | 52 | 48 | 48 | 54 | 54 | 55 | 58 | 57 | 58 | 57 | 60 | 56 | 58 | 61 | 70 | 77 | 84 | 98 | 101 | 104 | 108 |
| Interest | 10 | 21 | 27 | 25 | 35 | 53 | 46 | 45 | 27 | 27 | 25 | 22 | 22 | 22 | 20 | 20 | 19 | 9 | 11 | 21 | 24 | 34 | 52 | 55 | 55 | 54 |
| Profit Before Tax | 9 | -0 | -6 | 10 | -300 | 22 | 105 | 105 | 190 | 182 | 213 | 154 | 216 | 265 | 281 | 301 | 304 | 366 | 360 | 336 | 321 | 374 | 309 | 403 | 400 | 446 |
| Tax | -0 | 1 | -4 | -43 | 14 | 6 | 15 | 35 | 43 | 37 | 23 | 31 | 44 | -192 | 59 | 50 | 63 | 90 | 70 | 84 | 85 | 92 | 70 | 84 | 93 | -45 |
| Net Profit | 9 | -1 | -2 | 53 | -314 | 17 | 90 | 70 | 147 | 145 | 190 | 124 | 173 | 457 | 222 | 251 | 240 | 277 | 289 | 252 | 236 | 282 | 239 | 319 | 308 | 491 |
| EPS in ₹ | 0.17 | -0.03 | -0.03 | 0.91 | -4.34 | 0.18 | 1.00 | 0.76 | 1.52 | 1.50 | 1.96 | 1.28 | 1.78 | 4.72 | 2.29 | 2.58 | 2.47 | 2.85 | 2.98 | 2.59 | 2.43 | 2.90 | 2.46 | 3.28 | 3.17 | 5.05 |
Max Healthcare Institute
Max Healthcare Institute
1,013.60
-23.40
(-2.26%)
Market Cap
98,599.90 Cr
PE Ratio
74.30
Volume
23,22,646.00
Day High - Low
1,038.40 - 1,010.50
52W High-Low
1,314.30 - 940.05
Key Fundamentals
Market Cap
98,599.90 Cr
EPS
11.07
PE Ratio
74.30
PB Ratio
10.03
Book Value
103.32
EBITDA
2,004.40
Dividend Yield
0.14 %
Industry
Healthcare Services Sector
Hospitals Return on Equity
11.47
Debt to Equity
0.24
Analyst Rating and Forecast
- By Refinitiv from21 analysts
Actual
Company News
View All News
Macquarie Raises Max Health Target to ₹825
10 days ago
10 days agoMacquarie maintains Underperform rating on Max Healthcare Institute while significantly raising target price to ₹825 from ₹615, representing a 34% increase in valuation despite cautious outlook.
Max Healthcare Block Trade Worth ₹15.59 CroresJan 07, 2026
Jan 07, 2026Max Healthcare Institute executed a significant NSE block trade involving 151,175 shares at ₹1,031.40 per share, totaling ₹15.59 crores in transaction value.
Max Healthcare Faces ₹55.20 Cr GST ClaimDec 31, 2025
Dec 31, 2025Max Healthcare Institute receives GST claim of ₹55.20 crores for possible excess input tax credit and initiates rectification and appeal procedures to address the matter.
View more
Peer Comparison Compare Peers on Screener
Competitors | LTP | Market Cap (₹ Cr.) | P/E Ratio | Revenue (₹ Cr.) | YoY Revenue Growth % | Net Profit (₹ Cr.) | YoY Profit Growth % | RSI |
|---|---|---|---|---|---|---|---|---|
7,133.00 | #1 1,02,561.60 | 60.18 | #1 21,994.30 | 14.76 | #1 1,505 | 24.84 | 45.34 | |
1,013.60 | #2 98,599.90 | #7 74.30 | #3 7,184.10 | #1 28.65 | #2 1,076 | #1 74.34 | 35.62 | |
892.05 | 67,346.04 | 65.21 | 7,849.70 | 13.25 | 809 | 70.27 | 45.15 | |
1,862.10 | 38,054.03 | #1 46.38 | 5,575.00 | 12.29 | 790 | 30.03 | 45.39 | |
1,114.30 | 29,951.31 | 54.78 | 3,771.40 | 12.59 | 481 | 21.10 | 36.20 | |
573.00 | 29,688.33 | 85.17 | 4,286.70 | 15.12 | 337 | 14.65 | 30.00 | |
611.05 | 24,450.49 | 69.09 | 3,067.00 | 21.98 | 415 | -40.35 | 40.13 | |
479.75 | 15,182.65 | 105.39 | 1,757.00 | 27.64 | 110 | 71.36 | 34.67 | |
1,259.00 | 12,786.30 | 50.41 | 1,566.90 | 17.46 | 244 | -4.30 | 31.29 | |
650.15 | 9,167.61 | 221.46 | 2,257.70 | 17.03 | 49 | 0.00 | 39.78 |
Automatic Screeners on ScanX
Growth Rate
Revenue Growth
28.65 %
Net Income Growth
1.73 %
Cash Flow Change
30.09 %
ROE
-8.82 %
ROCE
-11.54 %
EBITDA Margin (Avg.)
-6.72 %
Quarterly Financial Results
Balance Sheet
| Balance Sheet | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
| Total Assets | 1,453 | 2,217 | 3,160 | 3,314 | 3,366 | 3,974 | 8,544 | 9,189 | 10,102 | 12,000 | 15,215 |
| Fixed Assets | 740 | 1,478 | 2,244 | 2,227 | 2,192 | 851 | 6,536 | 7,018 | 7,039 | 8,784 | 11,502 |
| Current Assets | 383 | 289 | 349 | 454 | 447 | 2,915 | 1,125 | 1,000 | 1,943 | 1,706 | 1,593 |
| Capital Work in Progress | 18 | 12 | 46 | 38 | 87 | 28 | 27 | 151 | 252 | 553 | 901 |
| Investments | 143 | 0 | 0 | 0 | 1 | 2,182 | 1 | 1 | 1 | 2 | 3 |
| Other Assets | 552 | 728 | 870 | 1,049 | 1,086 | 913 | 1,981 | 2,020 | 2,810 | 2,661 | 2,809 |
| Total Liabilities | 1,453 | 2,217 | 3,160 | 3,314 | 3,366 | 3,974 | 8,544 | 9,189 | 10,102 | 12,000 | 15,215 |
| Current Liabilities | 282 | 419 | 381 | 477 | 1,140 | 1,010 | 777 | 757 | 1,046 | 1,249 | 1,814 |
| Non Current Liabilities | 339 | 672 | 1,660 | 1,806 | 1,262 | 411 | 2,129 | 2,149 | 1,647 | 2,343 | 4,020 |
| Total Equity | 832 | 1,127 | 1,119 | 1,031 | 963 | 2,553 | 5,639 | 6,283 | 7,410 | 8,408 | 9,381 |
| Reserve & Surplus | 343 | 587 | 655 | 627 | 426 | 2,016 | 4,673 | 5,313 | 6,439 | 7,436 | 8,409 |
| Share Capital | 489 | 533 | 537 | 537 | 537 | 537 | 966 | 970 | 971 | 972 | 972 |
Cash Flow
| Cash Flow | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
| Net Cash Flow | 16 | -40 | 4 | -6 | -2 | -211 | 516 | -318 | 893 | -395 | -319 |
| Investing Activities | -194 | -364 | -104 | -124 | -17 | -2,641 | 206 | -772 | -102 | -1,253 | -1,614 |
| Operating Activities | 64 | 53 | 156 | 166 | 89 | 77 | 118 | 749 | 1,284 | 1,122 | 1,459 |
| Financing Activities | 145 | 271 | -48 | -48 | -74 | 2,353 | 191 | -294 | -289 | -264 | -164 |
Share Holding
| % Holding | Mar 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 |
| Promoter | 70.46 % | 70.46 % | 60.91 % | 60.68 % | 50.64 % | 50.64 % | 23.80 % | 23.78 % | 23.77 % | 23.76 % | 23.76 % | 23.75 % | 23.75 % | 23.74 % | 23.74 % | 23.74 % | 23.74 % | 23.74 % | 23.74 % | 23.72 % |
| FIIs | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.01 % | 0.01 % | 0.01 % | 0.00 % | 0.01 % | 0.01 % | 57.33 % | 56.98 % | 57.29 % | 56.93 % | 54.74 % | 54.76 % | 51.80 % | 50.55 % |
| DIIs | 4.86 % | 7.93 % | 8.70 % | 15.60 % | 17.49 % | 19.26 % | 21.00 % | 20.47 % | 19.35 % | 11.90 % | 11.32 % | 11.34 % | 14.96 % | 15.36 % | 15.14 % | 15.55 % | 17.58 % | 17.42 % | 20.03 % | 21.20 % |
| Government | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| Public / Retail | 5.18 % | 5.76 % | 5.20 % | 5.23 % | 5.41 % | 4.94 % | 4.54 % | 4.36 % | 3.72 % | 3.54 % | 3.55 % | 3.34 % | 3.29 % | 3.24 % | 3.18 % | 3.13 % | 3.31 % | 3.42 % | 3.08 % | 3.13 % |
| Others | 19.50 % | 15.84 % | 25.18 % | 18.49 % | 26.46 % | 25.16 % | 50.65 % | 51.38 % | 53.15 % | 60.80 % | 61.36 % | 61.56 % | 0.67 % | 0.67 % | 0.65 % | 0.64 % | 0.63 % | 0.66 % | 1.35 % | 1.38 % |
| No of Share Holders | 45,339 | 70,655 | 91,937 | 1,11,877 | 1,20,079 | 1,05,000 | 1,01,659 | 1,11,701 | 1,04,656 | 1,11,374 | 1,18,635 | 1,11,338 | 1,27,009 | 1,36,254 | 1,37,856 | 1,40,028 | 1,51,633 | 1,62,119 | 1,80,891 | 2,03,837 |
Dividend History
| Annual Cash Flows | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Per Share (₹) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1 | 1.5 | 1.5 | 0.00 |
| Dividend Yield (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.12 | 0.14 | 0.14 | 0.00 |
Corporate Action
| Record Date | Corporate Action | Information | Announcement Day | LTP at Annoucement | LTP at Record Day |
|---|---|---|---|---|---|
| 08 Sept 2023 |  Dividend | ₹ 1.00 /share | 08 Sept 2023 | 519.90 | 602.65 |
| 27 Sept 2023 |  Annual General Meeting | NA | 27 Sept 2023 | 553.60 | 566.10 |
| 23 Aug 2024 | Dividend | ₹ 1.50 /share | 23 Aug 2024 | 835.15 | 869.30 |
| 20 Sept 2024 | Annual General Meeting | NA | 20 Sept 2024 | 882.75 | 984.55 |
| 05 Nov 2024 |  Quarterly Result Announcement | NA | 05 Nov 2024 | 994.50 | 1,036.60 |
| 30 Jan 2025 | Quarterly Result Announcement | NA | 30 Jan 2025 | 1,082.95 | 1,025.90 |
| 20 May 2025 | Quarterly Result Announcement | NA | 20 May 2025 | 1,159.90 | 1,187.10 |
| 04 Jul 2025 | Dividend | ₹ 1.50 /share | 04 Jul 2025 | 1,187.10 | 1,301.40 |
| 30 Jul 2025 | Annual General Meeting | NA | 30 Jul 2025 | 1,190.20 | 1,274.30 |
| 13 Aug 2025 | Quarterly Result Announcement | NA | 13 Aug 2025 | 1,272.30 | 1,260.60 |
| 14 Nov 2025 | Quarterly Result Announcement | NA | 14 Nov 2025 | 1,135.30 | 1,098.00 |
Announcements
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 06, 2026
Jan 06, 2026Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPSJan 02, 2026
Jan 02, 2026Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Dec 30, 2025
Dec 30, 2025Closure of Trading WindowDec 29, 2025
Dec 29, 2025Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Dec 19, 2025
Dec 19, 2025Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseDec 18, 2025
Dec 18, 2025Announcement under Regulation 30 (LODR)-AcquisitionDec 18, 2025
Dec 18, 2025Outcome Of Board MeetingDec 18, 2025
Dec 18, 2025Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Dec 09, 2025
Dec 09, 2025Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPSDec 03, 2025
Dec 03, 2025Announcement under Regulation 30 (LODR)-Earnings Call TranscriptNov 21, 2025
Nov 21, 2025Announcement under Regulation 30 (LODR)-Investor PresentationNov 19, 2025
Nov 19, 2025Announcement under Regulation 30 (LODR)-Investor PresentationNov 17, 2025
Nov 17, 2025Audio Recording Of Earnings Call Held On November 17 2025Nov 17, 2025
Nov 17, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationNov 16, 2025
Nov 16, 2025Presentation On Earnings UpdateNov 14, 2025
Nov 14, 2025Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseNov 14, 2025
Nov 14, 2025Board Meeting Outcome for Meeting Held On November 14 2025Nov 14, 2025
Nov 14, 2025Results - Financial Results For The Quarter And Half Year Ended September 30 2025Nov 14, 2025
Nov 14, 2025Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPSNov 14, 2025
Nov 14, 2025Grant Of Options Under Max Healthcare Institute Limited - Employee Stock Option Scheme 2022Nov 14, 2025
Nov 14, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationNov 13, 2025
Nov 13, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationNov 10, 2025
Nov 10, 2025Board Meeting Intimation for Consideration And Approval Of Financial ResultsNov 08, 2025
Nov 08, 2025Approval Of Scheme Of Amalgamation Between Crosslay Remedies Limited And Jaypee Healthcare LimitedNov 07, 2025
Nov 07, 2025Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Nov 07, 2025
Nov 07, 2025Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Oct 22, 2025
Oct 22, 2025Communication To Members - 100 Days Campaign - Saksham NiveshakOct 09, 2025
Oct 09, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Oct 07, 2025
Oct 07, 2025Announcement under Regulation 30 (LODR)-Credit RatingOct 02, 2025
Oct 02, 2025Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Oct 01, 2025
Oct 01, 2025Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Sep 29, 2025
Sep 29, 2025Closure of Trading WindowSep 26, 2025
Sep 26, 2025Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Sep 22, 2025
Sep 22, 2025Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPSSep 04, 2025
Sep 04, 2025Announcement under Regulation 30 (LODR)-Investor PresentationAug 29, 2025
Aug 29, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationAug 27, 2025
Aug 27, 2025Announcement under Regulation 30 (LODR)-Earnings Call TranscriptAug 21, 2025
Aug 21, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 14, 2025
Aug 14, 2025Audio Recording Of Earnings Call Held On August 14 2025Aug 14, 2025
Aug 14, 2025Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Aug 14, 2025
Aug 14, 2025Agreement To Lease For Establishing A ~130 Bedded Built-To-Suit Hospital At Dehradun UttarakhandAug 13, 2025
Aug 13, 2025Presentation On Earnings UpdateAug 13, 2025
Aug 13, 2025Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseAug 13, 2025
Aug 13, 2025Board Meeting Outcome for Meeting Held On August 13 2025Aug 13, 2025
Aug 13, 2025Results - Financial Results For Quarter Ended June 30 2025Aug 13, 2025
Aug 13, 2025Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPSAug 12, 2025
Aug 12, 2025Grant Of Options Under Max Healthcare Institute Limited - Employee Stock Option Scheme 2022Aug 12, 2025
Aug 12, 2025Minutes Of 24Th Annual General MeetingAug 07, 2025
Aug 07, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationAug 06, 2025
Aug 06, 2025Mutual Fund Holdings
Technical Indicators
RSI(14)
Neutral 42.08
ATR(14)
Less Volatile 22.87
STOCH(9,6)
Neutral 38.15
STOCH RSI(14)
Neutral 69.18
MACD(12,26)
Bullish 0.78
ADX(14)
Strong Trend 32.85
UO(9)
Bearish 60.20
ROC(12)
Downtrend And Accelerating -0.37
WillR(14)
Neutral -48.50
About Max Healthcare Institute
Max Healthcare Institute Limited is an Indian integrated healthcare provider operating a network of healthcare facilities, primarily in North India. The company offers a range of medical services including primary, secondary, tertiary, and quaternary care across various specialties. It operates 17 healthcare facilities in Delhi NCR, Haryana, Punjab, Uttarakhand, and...more
Website
Chairperson NameAbhay Soi
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
